Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Invited commentary: the importance of prevalence in the effectiveness of a (bio)marker.
Authors: Ghosh A,  Castle PE
Journal: Am J Epidemiol
Date: 2011 Jun 15
Branches: BB, MEB
PubMed ID: 21571873
PMC ID: PMC3145395
Abstract: Metrics such as relative hazards and relative risks do not account for the prevalence of a marker over time and its relation to whether and when an outcome occurs. Uncommon markers that have good predictive values and common markers that are poorly predictive may not be (clinically) useful in predicting disease and other health outcomes. Recent work by Little et al. (Am J Epidemiol. 2011;173(12):1380-1387) highlights the development of a new method that considers both factors in predicting outcomes. Measures that incorporate both marker prevalence and predictive values and therefore are measures of "effectiveness" may be broadly helpful in deciding which markers or exposures are useful in disease screening or should be targeted by health interventions.